Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NASDAQ:MDGN)

5.00
Delayed Data
As of 3:59pm ET
 -0.06 / -1.19%
Today’s Change
3.09
Today|||52-Week Range
7.18
-16.94%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$187.7M

Company Description

Medgenics, Inc. is a medical technology company, which develops protein therapeutics medical therapies. Its Transduced Autologous Restorative Gene Therapy platform is designed to provide sustained protein and peptide therapies to treat a range of chronic diseases and conditions. The Company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.

Contact Information

Medgenics, Inc.
435 Devon Park Drive
Wayne Pennsylvania 19087
P:(610) 254-4201
Investor Relations:

Employees

Shareholders

Other institutional31.84%
Individual stakeholders13.25%
Mutual fund holders12.65%

Top Executives

Michael F. ColaPresident, Chief Executive Officer & Director
Brian D. PiperChief Financial Officer
Nir ShapirSenior Vice President-Research & Development
Garry Arthur NeilChief Scientific Officer
David FittsVP, Head-Statistical Sciences & Data Management